NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII products
This is a contract result notice, not an open opportunity. Details from the official award data.
This is a large award for Medical Equipment & Pharmaceuticals — above three-quarters of comparable contracts. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.
NHS National framework agreement for the supply of Human Cell Line Recombinant Factor VIII products.
The framework will commence on 1st July 2016 to 31st March 2017, with options to extend for up to a further 39 months.
Please refer to the ITO, Document No.05d for a list of Participating Authorities.
What the supplier must deliver
NHS National framework agreement for the supply
NHS National framework agreement for the supply of Human Cell Line Recombinant Factor VIII products.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at COMMERCIAL MEDICINES UNIT, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- bf1cdcad-df59-4c76-814c-eb270e2319ac
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CM/PHS/16/5501
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
COMMERCIAL MEDICINES UNIT’s tender network
Assembling the network…